Effector mechanisms in low-dose streptozotocin-induced diabetes

Developmental Immunology

Volumn 6, Issue 1-2, 1998, Pages 119-128

  Lukić, Miodrag L ^a,b   Stošić Grujičić, Stanislava ^b   Shahin, Allen ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Insulin dependent diabetes mellitus; Interferon ; Interleukin 1; Interleukin 1 inhibitor; Nitric oxide; RT6+ T cells; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; MERCURY; NITRIC OXIDE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DIABETOGENESIS; DISEASE PREDISPOSITION; HELPER CELL; MACROPHAGE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; T LYMPHOCYTE;

ANIMALIA;

EID: 0031686176     PISSN: 10446672     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/92198     Document Type: Conference Paper

References (59)

1. Al-Balaghi S., Möller E., Möller G., and Abedi-Valugerdi M. (1996). Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB X NSW) F1 hybrids. Eur. J. Immunol. 26: 1519-1526.
2. Appels B., Burkart V., Kantwerk-Funke G., Funda J., Kolb-Bachofen V., and Kolb H. (1989). Spontaneous cytotoxicity of macrophages against pancreatic islet cells. J. Immunol. 142: 3803-3808.
3. Arsov I., Pravica V., Ejdus L., Badovinac M., and Lukic M.L. (1995). Selection for the susceptibility to experimental allergic encephalomyelitis also selects for high IFN-γ production. Transplant. Proc. 27: 1537-1538.
4. Bendtzen K., Mandruop-Poulsen T., Nerup J., Nielsen J.H., Dinarello C.A., and Svenson M. (1986). Cytotoxicity of human pi 7 interleukin-1 for pancreatic islets of Langerhans. Science 232: 1545-1547.
5. G-monomethyl-L-arginine. FEBS Lett. 299: 103-106.
6. Bolaffi J.L., Rodd G.G., Wang J., and Grodsky G.M. (1994). Interrelationship of changes in islet nicotine adeninedinucleotide, insulin secretion, and cell viability induced by interleukin-β. Endocrinology 134: 537-542.
7. Bougneres P.F., Carel J.C., Castano L., Boitard C., Gardin J.P., Landais P., Hors J., Mihatsch M.J., Paillard M., Chaussain J.L., and Bach J.F. (1988). Factors associated with early remission of type I diabetes in children treated with cyclosporin. N. Engl. J. Med. 318: 663-670.
8. Brenner H.H., Burkart V., Rothe H., and Kolb H. (1993). Oxygen radical production is increased in macrophages from diabetes prone BB rats. Autoimmunity 15: 93-98.
9. Campbell I.L., Kay T.W.H., Oxbrow L., and Harrison L.C. (1991): Essential role for interferon gamma and interleukin 6 in autoimmune insulin-dependent diabetes in NOD/Wehi Mice. J. Clin. Investig. 87: 739-742.
10. Corbett J.A., Lancaster J.R., Sweetland M.A., and McDaniel M.L. (1991). Interleukin-1β-induced formation of EPR-detectable iron nitrosyl complexes in islets of Langerhans. Biol. Chem. 266: 21351-21354.
11. Corbett J.A., and McDaniel M.L. (1992). Does nitric oxide mediate autoimmune destruction of β cells? Possible therapeutic interventions in IDDM. Diabetes 41: 897-903.
12. Corbett J.A., and McDaniel M.L. (1995). Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J. Exp. Med. 181: 559-568.
13. Corbett J.A., Mikhael A., Shimizu J., Frederick K., Misko T.P., McDaniel M.L., Konagawa O., and Unanue E.R. (1993). Nitric oxide production in islets from nonobese diabetic mice: Aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA 90: 8992-8995.
14. Delaney C.A., Green M.H.L., Lowe J.E., and Green I.C. (1993). Endogenous nitric oxide induced by interleukin-β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the "cometi" assay. FEES Lett. 333: 291-295.
15. Dunger A., Cunnigham J.M., Delaney C.A., Lowe J.E., Green M.H.L., Bone A.J., and Green I.C. (1996). Tumor necrosis factor-α and Interferon-γ inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement. Diabetes 45: 183-189.
16. Eizirik D.L. (1988). Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol. 119: 321-325.
17. Eizirik D.L., Sandler S., Welsh N., et al. (1994). Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 93: 1968-1974.
18. + lymphocytes induces diabetes in resistant BB/W rats. J. Exp. Med. 166: 461-469.
19. Hanenberg H., Kolb-Bachofen V., Kantwerk-Funke G., and Kolb H. (1989). Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 32: 126-134.
20. Huang X., Yuan J., Goddard A., Foulis A., James R.F.L., Lernmark A., Pulol-Borrell R., Rabinovitch A., Somoza N., and Stewart T.A. (1995). Interferon expression in the pancreas of patients with type I diabetes. Diabetes 44: 658-664.
21. Hutchings P., Rosen H., O'Reilly L., Simpson E., Gordon S., and Cooke A. (1990). Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348: 639-642.
22. Issekutz T.B., Stoltz J.M., and Van der Meide P. (1988). Lymphocyte recruitment in delayed-typed hypersensitivity. The role of IFNγ. J. Immunol. 140: 2989-2993.
23. Jacob C.O., Aiso S., Michie S.A., McDevitt H.O., and Acha-Orbea H. (1990). Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin-1. Proc. Natl. Acad. Sci. USA 87: 968-972.
24. Karlsen A.E., Andersen H.U., Vissing H., et al. (1995). Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 44: 753-758.
25. Knowles R.G., and Moncada S. (1994). Nitric oxide synthases in mammals. Biochem. J. 298: 249-258.
26. Kolb H., Kiesel U., Kroncke K.D., and Kolb-Bachofen W. (1991). Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. Life Sci. 49: P1213-P1217.
27. Kolb-Bachofen V., Epstein S., Kiesel U., and Kolb H. (1988). Low dose streptozotocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes 37: 21-27.
28. Kröncke K., Funda J., Berschick B., and Kolb-Bachofen V. (1991a). Macrophage cytotoxicity towards isolated rat islet cells: Neither lysis nor its protection by nicotinamide are beta-cell specific. Diabetologia 34: 232-238.
29. Kröncke K., Kolb-Bachofen V., Berschick B., Burkart V., and Kolb H. (1991b). Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun. 175: 752-758.
30. Lampeter E.F., Homerg M., Quabeck K., Schaefer U.W., Wernet P., Bertrams J., Crosswilde H., Gries F.A., and Kolb H. (1993). Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341: 1243-1244.
31. Leramark A., Kloppel G., and Stenger D. (1995). Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch. 425: 631-640.
32. w-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 44: 365-368.
33. Lukic M.L., Al-Sharif R., Mostarica M., Bahr G., and Behbehani K. (1991). Immunological basis of the strain differences in susceptibility to low-dose streptozotocin-induced diabetes in rats. In Lymphatic Tissues and In vivo Immune Responses, Imhof, et. al., Eds. (New York: Marcel Dekker), pp. 643-647.
34. Lukic M.L., Mostarica Stojkovic M., Kostic M., Tucic N., and Vukmanovic S. (1987). Cellular and genetic basis of the strain differences in IL2 production in rats. Transpl. Proc. 19: 3137-3139.
35. Lukic M.L., and Stosic S. (1993). Interleukin 1 receptor antagonists prevent the induction of autoimmune diabetes. Autoimmunity 14 (Suppl. 1): 12.
36. Lukic M.L., Stosic-Grujicic S., Ostqjic N., Chan W.L., and Liew F.Y. (1991). Inihibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice Biochem. Biophys. Res. Commun. 178: 913-920.
37. Mandrup-Poulsen T. (1996). The role of interleukin-1 in the pathogenesis of IDDM (Review). Diabetologia 39: 1005-1029.
38. Nicoletti F., Di Marco R., Barcellini W., et al. (1994). Protection from experimental autoimmune diabetes in the nonobese diabetic mouse with soluble interleukin-1 receptor. Eur. J. Immunol. 24: 1843-1847.
39. Oschilewski U., Kiesel U., and Kolb H. (1985). Administration of silica prevents diabetes in BB-rats. Diabetes 34: 197-199.
40. Pennline K.J., Rouque-Gaffney E., and Monahan M. (1994). Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71: 169-175.
41. + T cells. Transplant. Proc. 25: 2835-2836.
42. Rabinovitch A., Suarez-Pinzon W., El-Sheikh A., Sorensen O., and Power R.F. (1996). Cytokine gene expression in pancreatic isletinfiltrating leukocytes of BB rats. Expression of Th1 cytolines correlates with β-cell destructive insulitis and IDDM. Diabetes 45: 749-754.
43. Reimers J.I., Andersen H.U., Mauricio D., Pociot F., Karlsen A.E., Petersen J.S., Mandrup-Poulsen T., and Nerup J. (1996). Diabetes 45: 771-778.
44. Rigby M.R., Bortell R., Greiner D.L., Czech M.P., Klarlund J.K., and Mordes J.P. (1996). The rat T-cell surface protein RT6 is associated with src family tyrosine kinases and generates an activation signal. Diabetes 45: 1419-1426.
45. Sandler S., Andersson A., and Hellerström C. (1987). Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121: 1424-1431.
46. Saoudi A., Kuhn J., Huygen K., de Kozak Y., Velu T., Goldman M., Druet P., and Bellon B. (1993). TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur. J. Immunol. 23: 3096-3103.
47. Shahin A., Mahmoud T.A.M., and Lukic M.L. (1995). Transforming growth factor β and inteferon gamma modulate the development of Th-1 mediated autoimmunity in susceptible and resistant strains of rats. Transplant. Proc. 27: 1535-1536.
48. Sibley R., Sutherland D.E.R., Goetz F., and Michael A.F. (1985). Recurrent diabetes mellitus in the pancreas iso- and allograft: A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest. 53: 132-144.
49. Southern C., Schulster D., and Green I.C. (1990). Inhibition of insulin secretion by interleukin-1b and tumour necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEES Lett. 276: 42-44.
50. Stenger S., Thüring H., Röllinghoff M., and Bogdan C. (1994). Tissue expression of inducible nitric oxide synthase is closely associated with resistance to lieshmania major. J. Exp. Med. 180: 783-793
51. Stosic-Grujicic S., and Lukic M.L. (1992). Glucocorticoid-induced keratinocyte-derived interleukin-1 receptor antagonist(s). Immunology 75: 293-298.
52. Stosic-Grujicic S., Mijatovic S., Ejdus L. and Lukic M.L. (1996). Enhancement of Th2-type activity downregulated diabetes induction. Transplant. Proc. 28(6): 3259.
53. Strandell E., Buschard K., Saldeen J., and Welsh N. (1995). Interleukin-1β induces the expression of HSP70, heme oxygenase and Min-SOD in FACS-purified rat islet β-cells, but not in α-cells. Immunol. Lett. 48: 145-148.
54. + T-Cells in syngeneic islet grafts in NOD mice produce Interferon-γ during β cell destruction. Diabetes 4: 1350-1357.
55. Tilag H., Atkins M.B., Dinarello C.A., and Mier J.W. (1995). Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy. Cytokine 7: 734-739.
56. Vukmanovic S., Mostarica Stojkovic M, Zalud I., Ramic Z., and Lukic M.L. (1990). Analysis of T cell subsets after induction of experimental autoimmune encephalomyelitis in susceptible and resistant strains of rats. J. Neuroimmunol. 27: 63-69.
57. Wel X., Charles I.G., Smith A., Ure J., Feng G., Huang F., Xu D., Muller W., Moncada S., and Liew F.Y. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-410.
58. Wilson C.A., Jacobs C., Baker P., Baskin D.G., Dower S., Lernmark A., et al. (1990). IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J. Immunol. 144: 3784-3788.
59. G-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Diabetes 44: 360-364.